Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 1261 AL 1275

Rescuing neurons in prion disease

Verity NC, Mallucci GR.

Biochem J. 2011 Jan 1;433(1):19-29. doi: 10.1042/BJ20101323.

Huntington's disease: from molecular pathogenesis to clinical treatment

Ross CA, Tabrizi SJ.

Lancet Neurol. 2011 Jan;10(1):83-98. doi: 10.1016/S1474-4422(10)70245-3.

Association of micronucleus frequency with neurodegenerative diseases

Migliore L, Coppedè F, Fenech M, Thomas P.

Mutagenesis. 2011 Jan;26(1):85-92. doi: 10.1093/mutage/geq067.

Induction of the unfolded protein response by α-synuclein in experimental models of Parkinson's disease

Bellucci A, Navarria L, Zaltieri M, Falarti E, Bodei S, Sigala S, Battistin L, Spillantini M, Missale C, Spano P.

J Neurochem. 2011 Feb;116(4):588-605. doi: 10.1111/j.1471-4159.2010.07143.x. Epub 2011 Jan 19.

Neuronal activity regulates expression of tyrosine hydroxylase in adult mouse substantia nigra pars compacta neurons

Aumann TD, Egan K, Lim J, Boon WC, Bye CR, Chua HK, Baban N, Parish CL, Bobrovskaya L, Dickson P, Horne MK.

J Neurochem. 2011 Feb;116(4):646-58. doi: 10.1111/j.1471-4159.2010.07151.x. Epub 2011 Jan 19.

Unclassifiable tauopathy associated with an A152T variation in MAPT exon 7

Kovacs GG, Wöhrer A, Ströbel T, Botond G, Attems J, Budka H.

Clin Neuropathol. 2011 Jan-Feb;30(1):3-10. doi: 10.5414/npp30003.

Mechanisms of mitophagy

Youle RJ, Narendra DP.

Nat Rev Mol Cell Biol. 2011 Jan;12(1):9-14. doi: 10.1038/nrm3028.

Regulation of PINK1-Parkin-mediated mitophagy

Springer W, Kahle PJ.

Autophagy. 2011 Mar;7(3):266-78. doi: 10.4161/auto.7.3.14348.

Converging pathways in the occurrence of endoplasmic reticulum (ER) stress in Huntington's disease

Vidal R, Caballero B, Couve A, Hetz C.

Curr Mol Med. 2011 Feb;11(1):1-12. doi: 10.2174/156652411794474419.

Advances pertaining to the pharmacology and interactions of irreversible nonselective monoamine oxidase inhibitors

Gillman PK.

J Clin Psychopharmacol. 2011 Feb;31(1):66-74. doi: 10.1097/JCP.0b013e31820469ea.

Aripiprazole-associated bruxism, akathisia, and parkinsonism in a bipolar patient

Caykoylu A, Ekinci O, Ugurlu GK, Albayrak Y.

J Clin Psychopharmacol. 2011 Feb;31(1):134-5. doi: 10.1097/JCP.0b013e3182048cce.

Becker myotonia congenita associated with Wolff-Parkinson-White syndrome

Caballero PE.

Neurologist. 2011 Jan;17(1):38-40. doi: 10.1097/NRL.0b013e3181d35c93.

High-Throughput and High-Content Screening for Huntington’s Disease Therapeutics

Varma H, Lo DC, Stockwell BR.

In: Lo DC, Hughes RE, editors. Neurobiology of Huntington's Disease: Applications to Drug Discovery. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 5.

Value of Invertebrate Genetics and Biology to Develop Neuroprotective and Preventive Medicine in Huntington’s Disease

Neri C.

In: Lo DC, Hughes RE, editors. Neurobiology of Huntington's Disease: Applications to Drug Discovery. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 6.

Huntington’s Disease Pathogenesis: Mechanisms and Pathways

La Spada AR, Weydt P, Pineda VV.

In: Lo DC, Hughes RE, editors. Neurobiology of Huntington's Disease: Applications to Drug Discovery. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias